Nutrients 2011, 3(6), 637-682; doi:10.3390/nu3060637
Review

Gut Microbiota and Inflammation

Received: 15 April 2011; in revised form: 19 May 2011 / Accepted: 24 May 2011 / Published: 3 June 2011
(This article belongs to the Special Issue Probiotics and Nutrition)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Systemic and local inflammation in relation to the resident microbiota of the human gastro-intestinal (GI) tract and administration of probiotics are the main themes of the present review. The dominating taxa of the human GI tract and their potential for aggravating or suppressing inflammation are described. The review focuses on human trials with probiotics and does not include in vitro studies and animal experimental models. The applications of probiotics considered are systemic immune-modulation, the metabolic syndrome, liver injury, inflammatory bowel disease, colorectal cancer and radiation-induced enteritis. When the major genomic differences between different types of probiotics are taken into account, it is to be expected that the human body can respond differently to the different species and strains of probiotics. This fact is often neglected in discussions of the outcome of clinical trials with probiotics.
Keywords: probiotics; inflammation; gut microbiota
PDF Full-text Download PDF Full-Text [739 KB, uploaded 3 June 2011 09:58 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Hakansson, A.; Molin, G. Gut Microbiota and Inflammation. Nutrients 2011, 3, 637-682.

AMA Style

Hakansson A, Molin G. Gut Microbiota and Inflammation. Nutrients. 2011; 3(6):637-682.

Chicago/Turabian Style

Hakansson, Asa; Molin, Goran. 2011. "Gut Microbiota and Inflammation." Nutrients 3, no. 6: 637-682.

Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert